United Kingdom · Series B startup

Who invested in Acacia Pharma

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$34Mraised across 2 rounds since 2011, from 2 sources

$10MSeries A$24MSeries B
Latest round
Series B, $24MSept 2013
Step-upi
2.4×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20122013
$10MSeries A$24MSeries B
First round
Series A, $10M
Mar 2011
Biggest round
$24M
Series B · Sept 2013
Between rounds
2.4 years
from the last two

The rounds

  1. Sept 2013
  2. Mar 2011

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

F-Prime CapitalVC firm1round
Novo Holdings A/SGrowth equity1round
Gilde HealthcarePrivate equity1round
Fidelity BiosciencesInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Acacia Pharma

Who invested in Acacia Pharma?

Acacia Pharma's investors include F-Prime Capital, Novo Holdings A/S, Gilde Healthcare, Fidelity Biosciences and Lundbeckfond Ventures.

How much has Acacia Pharma raised?

Acacia Pharma has raised $34M across 2 rounds since 2011.

When did Acacia Pharma last raise?

Acacia Pharma's most recent round was a Series B of $24M in Sept 2013.

What was Acacia Pharma's biggest round?

Its most recent round, $24M in Sept 2013, is also its largest on record.

Who backed Acacia Pharma first?

Acacia Pharma's first round on record, in Mar 2011, was backed by Gilde Healthcare and Lundbeckfond Ventures.

What stage is Acacia Pharma at?

Acacia Pharma's latest named round is a Series B, in Sept 2013.

Where is Acacia Pharma based?

Acacia Pharma is based in the United Kingdom.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.